-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fennec, Astra, Acutus, and Pulse and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telos, Fennec, Astra Space, and Acutus and Encourages Investors to Contact the Firm
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

